Diana Mckenzie - Net Worth and Insider Trading

Diana Mckenzie Net Worth

The estimated net worth of Diana Mckenzie is at least $131,755 dollars as of 2024-12-14. Diana Mckenzie is the Director of Agilon Health Inc and owns about 58,819 shares of Agilon Health Inc (AGL) stock worth over $131,755. Details can be seen in Diana Mckenzie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Diana Mckenzie has not made any transactions after 2024-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Diana Mckenzie

To

Diana Mckenzie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Diana Mckenzie owns 4 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , MetLife Inc (MET) , and Change Healthcare Inc (CHNG) among others .

Click here to see the complete history of Diana Mckenzie’s form 4 insider trades.

Insider Ownership Summary of Diana Mckenzie

Ticker Comapny Transaction Date Type of Owner
VRTX Vertex Pharmaceuticals Inc 2022-04-14 director
MET MetLife Inc 2022-01-03 director
CHNG Change Healthcare Inc 2019-08-01 director
LIMIT LIMIT 2023-02-17 director

Diana Mckenzie Latest Holdings Summary

Diana Mckenzie currently owns a total of 1 stock. Diana Mckenzie owns 58,819 shares of Agilon Health Inc (AGL) as of December 9, 2024, with a value of $131,755.

Latest Holdings of Diana Mckenzie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGL Agilon Health Inc 2024-12-09 58,819 2.24 131,755

Holding Weightings of Diana Mckenzie


Diana Mckenzie Form 4 Trading Tracker

According to the SEC Form 4 filings, Diana Mckenzie has made a total of 1 transactions in Agilon Health Inc (AGL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Agilon Health Inc is the acquisition of 20,000 shares on December 9, 2024, which cost Diana Mckenzie around $45,000.

Insider Trading History of Diana Mckenzie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Diana Mckenzie Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Diana Mckenzie Ownership Network

Ownership Network List of Diana Mckenzie

No Data

Ownership Network Relation of Diana Mckenzie

Insider Network Chart

Diana Mckenzie Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Diana Mckenzie is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP & Global Research and CSO David Altshuler , EVP & Chief Financial Officer Wagner Charles F Jr , and director & CEO & President Reshma Kewalramani .

Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary

Over the past 18 months, Diana Mckenzie made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 92,430 shares made by Reshma Kewalramani , and a net sale of 16,533 shares made by Ourania Tatsis .

In summary, during the past 3 months, insiders sold 19,212 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 19,212 shares. During the past 18 months, 357,883 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 357,883 shares.

Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Diana Mckenzie Mailing Address

Above is the net worth, insider trading, and ownership report for Diana Mckenzie. You might contact Diana Mckenzie via mailing address: Metlife, 200 Park Avenue, New York Ny 10166.